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Abstract The cytotoxic properties of an amphiphilic synthetic 
peptide are presented. Comparative analysis of proliferating, 
differentiated and confluent H9C2 adherent cells and L1210 cells 
in suspension shows a correlation between toxicity and cell stage 
(proliferating cells). Electrophysiological measurements on 
Xenopus laevis oocytes bathed in the peptide also demonstrated 
the induction of cationic currents, which is voltage and phosphate 
dependent. These results allow us to hypothesize that the 
observed toxicity is related to membrane hyperpolarization of 
proliferating cells at the Gl /S cell cycle phase transition. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Synthetic peptides can be used to vectorize therapeutic mol-
ecules [1-3]. Their role involves crossing the plasma mem-
brane (and sometimes the nuclear membrane) to carry an 
active molecule into the cell. Often such peptide vectors 
present strong toxicity in cells [4,5]. 
The reason for peptide toxicity is most often intrinsically 
related to the design of the peptide, or a part may be soluble 
in the phospholipid membrane as a transient anchor. More 
subtle additions to the design may include a hydrophilic re-
gion which improves aqueous solubility and the half-life of 
membrane residence. The resulting peptide might stay suffi-
ciently long in the membrane, before crossing into the cyto-
plasm. Two properties may thus originate from the amphi-
philic construction: (i) in aqueous environments the peptide 
has a great propensity to self-aggregate [6], (ii) in phospholip-
id environments, the structure of the membrane bilayer may 
be disturbed (by the peptide itself, its flip-flop action, mem-
brane aggregation and/or destruction of the bilayer itself). 
Without taking into account more biological properties of 
the peptide (for example, interference in phosphorylation cas-
cades), the aforementioned properties result in toxic behavior; 
generally, the peptide is discarded as too dangerous for ther-
apeutic use. At present, drugs (taxol, anthracyclins, etc.) are 
more generally used for killing proliferating cells. Amphiphilic 
peptides could be interesting tools, especially if they target 
proliferating cells [4,7]. The aim of this paper is to present a 
peptide designed to be used as a vector, but showing marked 
toxicity which preferentially targets proliferating cells. 
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2. Material and methods 
2.1. Dioleylphosphatidylglycerol vesicles 
Large unilamellar vesicles (LUV) were prepared from commercial 
dioleylphosphatidylglycerol (Sigma). Original solvent (CHCI3) was 
evaporated under a stream of nitrogen and desiccated under high 
vacuum for at least 3 h to remove the residual solvent, then DOPG 
was solubilized in chosen buffer. The resulting solution was sonicated 
( ~ 3 min 3 times at 80% pulse cycle in an ice bath) with a probe 
sonicator. 
2.2. Circular dichroism 
Dichroism spectra were recorded on a Mark V (JOBIN YVON, 
Paris) dichrograph equipped with a thermostatically controlled cell 
holder, and all spectra were recorded at 25°C. The cell (1 mm thin) 
used had been extensively washed with sulfochromic mixture and 
rinsed with double-distilled water to avoid the adsorption of the pep-
tide. The spectra shown are the mean values of five spectra. The scan 
rate was 20 nm/min and the data point number by scan around 650. 
Smoothing, structure assignation and percentage come from Green-
field et al. [9] and Dicroprot 2.3d software (G. Deleage, Lyon). 
2.3. Fluorescence intensity 
The emission spectra were obtained on a Spex 2000 (JOBIN 
YVON, Paris), the apertures being 2 mm for both slots, excitation 
and emission, and a high voltage of 950 V was applied. In all cases, 
the baseline corresponding to the buffer and DOPG vesicles was sub-
tracted from the given spectra. 
2.4. Cell culture and toxicity evaluation 
Rat embryo myoblasts (H9C2) were cultured in Dulbecco's modi-
fied Eagle's medium supplemented with 10% or 1% (in the case of 
differentiation assays) fetal calf serum (FCS). The cells (volume of 
medium 100 ul) were plated on glass coverslips and incubated in 35 
mm cell culture boxes (Nunc) for 24-48 h at 37°C. The peptide was 
added in 100 ul phosphate buffer 50 mM, pH 7.3. Toxicity was eval-
uated by determining trypan blue (Sigma Chemicals) exclusion versus 
a non-treated control. Murine lymphocytes (L1210) were cultured in 
RPMI (+Gln) medium supplemented with 8% FCS. Cells were sus-
pended in 1.5 ml medium in 35 mm cell culture boxes. FACS meas-
urements were performed after DNA staining using solution of PBS-
propidium iodide (0.1 mg/ml)-Triton X-100 (0.3%). The filters used 
(FL2A) were 530/617 (excitation/emission, respectively). 
2.5. Electrophysiological recording on Xenopus laevis oocyte 
Ovaries were surgically removed from Xenopus laevis females (El-
evage de Lavalette, Montpellier, France) and anesthetized using a 
0.2% MS222 solution (Sigma Chemicals). Oocytes were used after 
mechanical dissociation and extensive washing in OR-2 solution (in 
mM: NaCl 100; MgCl2 2; KC1 2; CaCl2 1.8; HEPES 10; pyruvic 
acid 2.5; gentamicin 50 ug/ml, neutralized at pH 7.2 using NaOH). 
Whole cell currents were recorded under two electrode voltage-clamp 
using the GeneClamp 500 amplifier (Axon Instr., Burlingame, CA). 
Current and voltage electrodes were filled with: CsCl 2.8 M; BAPTA 
10 mM, pH 7.2; with CsOH. The batch-clamp headstage was con-
nected to the bath using two agar bridges filled with 2%o agar in 3 M 
KC1. Before each recording, the electrode resistance was checked, and 
if necessary adjusted to less than 1 MQ, and the liquid junction po-
tential was nulled. The typical recording solution (NalOO) had the 
following composition (in mM): NaCl 100; HEPES 10; MgCl2 2; 
pH 7.2 with NaOH. Ionic selectivity was tested using several solu-
tions. Currents were filtered and digitized using a DMA-Tecmar lab-
master and subsequently stored on a IPC 486 personal computer 
using the version 6.02 of the pClamp software (Axon Instr.). Voltage 
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ramps (from —60 mV to +50 mV at 275 mV/s) were applied from a 
holding potential of —40 mV, —60 mV, —80 mV or —100 mV every 
5 s. The peptide was dissolved in an appropriate solution at 10 U.M 
and added directly to the recording chamber (250 |xl). Junction po-
tentials between the different solutions were less than 1 mV. 
2.6. Chemicals 
The peptide was synthesized using Fmoc strategy as described pre-
viously [8], The sequence of the peptide used was: NAc-
GALFLGWLGAAGSTMGAWSQPKKKRKV-Cya, where NAc is 
the acetylated N-terminus and Cya is the cysteamide group on the 
C-terminus. DOPG, solvents and buffer contents were purchased from 
Sigma Chemicals (St Quentin Fallavier, France). 
3. Results 
3.1. Secondary structure 
Fluorescence and circular dichroism studies were used to 
determine the peptide structure in a lipid environment. 
DOPG vesicles were chosen because they greatly reduce the 
light diffusion phenomena due to the high concentrations of 
lipid needed to reach the ratio Ri = 20 or Ri = 40 (see below), 
since they are transparent, in spite of their minor contribution 
to animal cell membranes. In the presence of liposomes, the 
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Fig. 1. A: Circular dichroism spectra (symbols = experimental, plain 
line = simulated) of 2X10-5 M peptide in aqueous medium: 
KH2P04 20 mM; pH = 7.2) O, and in presence of LUV (DOPG) in 
KH2PO4 20 mM, pH = 7.2. The ratio Ri = [lipid/peptide] is 20 (□) or 
40 ( A ) . B: Peptide fluorescence spectra corresponding to each solu-
tion shown in A, without DOPG (o), for Ri = 20 (□) and Ri = 40 
( A ) . 
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Fig. 2. FACS analysis of L1210 cells. A: Standard propidium iodide 
staining assay showing three phases of cell cycle. B: Analysis of the 
peptide effect (10 uM) after 24 h incubation. There is a persistence 
of the G0/G1 peak and a dramatic decrease of the two other popu-
lations. Much cell debris appears (arrow). 
peptide is incorporated into the phospholipid bilayer as shown 
by the fluorescence intensity measurements. Once excited at 
285 nm, the tryptophyl residues have an emission with a max-
imum wavelength shift from 353 to 338 nm (Fig. IB) which 
indicates a less polar environment for the chromophore [10]; 
the peptide can be considered to be embedded in the lipid 
bilayer. The peptide contains two tryptophans, one in the 
hydrophobic region (W7), the other near the hydrophilic re-
gion (W18), so the shift of the maximum wavelength is con-
sidered to be a mean value reflecting the two possible situa-
tions with respect to the bilayer. 
Under the same conditions, CD results show that the pep-
tide adopts mainly a p conformation in the presence of lip-
osomes, as indicated by the minimum occurring around 215 
nm (Fig. 1A). In aqueous solution, mainly a random coil 
conformation is observed with a typical spectrum (Fig. 1A) 
showing a minimum at 197 nm. The software used allows the 
determination of four major components: helix (h), sheet (s), 
turn (t) and coil (c); explicit results come from the Fasman 
algorithm:Without vesicles (o) : h = 7.4%, s=14.8%, t = 0%, 
c = 77.8%; Ri (lipid/peptide) = 20 (□): h = 9.5%, s = 76.2%, 
t = 0%, c=14,3%; Ri = 40 ( A ) : h=10.9%, s = 61%, t = 0%, 
c = 28.1%. 
3.2. Toxicity 
3.2.1. LI210. Preliminary experiments indicated that the 
peptide exerts toxic effect on murine L1210 cells. Fig. 2 shows 
a FACS analysis in which a substantial part of the cell pop-
ulation is killed. A decrease of G2 and S peaks (the latter 
being more affected) can be observed. 
3.2.2. H9C2. On the basis of these results, a more con-
venient cell line was chosen which can be more easily studied 
(adherent), not only under proliferative conditions, but also in 
confluent and differentiated states. 
3.2.3. Proliferating H9C2. The cell cultures were incu-
bated with the peptide solution when they reached 70% con-
fluence. Two experimental conditions were studied: 1% or 
10% FCS, which correspond to two different proliferation 
rates. As shown in Fig. 3, the toxicity is more marked for 
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the more rapidly proliferating cells (10% FCS; Fig. 3B) than 
for less rapidly proliferating cells (1% FCS; Fig. 3A). It de-
pends on at least two other factors: (i) the peptide concen-
tration and (ii) the contact time (1-3 days). After 3 days with 
a 10 MM initial peptide concentration, 100% of the cells were 
killed in 1% or 10% FCS. 
3.2.4. Differentiated H9C2. Serum deprivation induces 
H9C2 cell differentiation into myotubes [11]. Once the cells 
were differentiated (morphological phenotype), the peptide 
was added to the external medium, as a test to relate its 
toxicity after exit from the cell cycle. Under these conditions, 
the rate of cell death in cells induced to differentiate is about 
10%, roughly equivalent to the rate of cell death in untreated 
control cells. Thus as the cells leave the cycle and differentiate, 
no peptide induced toxicity is observed. 
When the H9C2 cells reach 100% confluence (a contiguous 
and continuous layer on the coverslip), the rate of peptide 
induced toxicity falls to about 30% of that observed in pro-
liferating (10% FCS) H9C2 cells (data not shown). This inter-
esting point is discussed further. 
3.3. Electrophysiological tests 
One possible explanation for this peptide induced toxicity 
could be cell membrane depolarization by the creation of 
pores. To test this hypothesis several electrophysiological 
measurements (whole cell current) were undertaken on Xeno-
pus laevis oocytes. The application of peptide to voltage 
clamped oocytes induced strong currents showing a potential 
reversal of ~—7 mV in typical 100 mM NaCl working sol-
utions (Fig. 4A). Replacing Na+ and Cl~ with different cati-
ons and anions, respectively, induced a potential reversal ser-
ies of currents, suggesting that the channels formed by the 
peptide were mainly for cations, without marked selectivity 
(data not shown). It is interesting to note that changes in 
membrane conductivity induced by the peptide were strongly 
voltage dependent, being larger for hyperpolarizing potentials 
(data not shown). This voltage dependence was lower when 
using phosphate ions in the external solution. Once induced, 
the membrane current did not reach a steady-state value and 
often oversaturated the capacity of our amplifier. Washing 
out the peptide did not reverse the effect, but led to a stabi-
lization of the peptide induced membrane current (Fig. 4B). 
Reversibility was only obtained when divalent cations (Ca2+ 
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Fig. 3. Toxicity evaluation on H9C2 cells (as percent death). Treat-
ment was for 24 h ( A ) , 48 h (♦) or 72 h (■). A: With DMEM, 
supplemented 1% FCS. IC50 remains between 1 and 10 uM. B: 
With DMEM, supplemented 10% FCS. IC50 is unchanged for 24 h. 






0 100 200 300 
Time (s) 
Fig. 4. A: Starting from a steady potential of —60 mV, a potential 
ramp is applied every 5 s. Erev is the current reversal potential char-
acteristic of the channel selectivity (see text). B: Current was meas-
ured at —40 mV (Vm, part A) during a series of voltage ramps sim-
ilar ro part A. Addition of 10 |xm peptide induced a marked 
increase of current at this potential, which did not reach a steady 
state with time. Wash out of the peptide (no Ca2+ solution) stabi-
lized this increase without reversibility. Reversibility could only be 
obtained if divalent cations were added to the washing solution 
(with Ca2+ solution). 
or Ba2+ 2 mM) were added to the bathing solution, suggesting 
an action of these ions on channel formation or gating stabil-
ity. The gating potential rises from —90 mV to —60 mV as the 
phosphate ions are present in the external medium. Further-
more, calcium ions reverse the conductance to zero; the nor-
mal behavior is then recovered by washing the oocyte with the 
working solution (2 mM CaCl2 added) (Fig. 4B). 
4. Discussion 
The problem of examining the effects of peptides in mam-
malian cells in culture is the requirement that the cells be 
physically broken, trypsinized or fixed. Consequently, global 
observations on quiescent cells such as Xenopus laevis oocytes 
seem to be more pertinent and informative. The electrophys-
iological measurements were undertaken to look for a possible 
role of the peptide in relation to membrane properties. It is 
known that membrane proteins such as porins (for example 
phosphate specific) are responsible for pore formation [12-17]. 
Such proteins are constructed as 16 antiparallel (3 strands [14]. 
When embedded in phospholipid membranes, the induced P 
strand formation of the peptide under study may be analo-
gous to the porins due to aggregation of the peptide molecules 
probably caused by an electroneutralization of positive 
charges, followed by the chain-chain interaction of the hydro-
phobic part (N-terminal). Such a structure may be possible 
within the structure of the membrane. 
In Xenopus laevis oocytes, we observed the induction of 
non-specific cationic currents. The addition of phosphate buf-
fer in the medium raised the gating potential from —90 to 
—60 mV. This latter value is a more normal level for mem-
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brane potentials than —90 mV. Furthermore, currents are 
reversed to zero by addition of calcium ions. The inhibition 
of the monovalent cation current by Ca2+ could be explained, 
for example, by a blocking behavior with respect to the hy-
drated radius of cations. No calcium current was detected, 
thus supporting the idea of a channel with a well defined 
pore dimension or a competition between Ca2+ and basic 
residues with respect to the phosphate ions of the lipids. 
Mg2+, which is much more hydrated than Ca2+, does not 
show any effect on current formation. 
In summary, (i) toxicity is observed on proliferating cells as 
a (3 structure exists in bilayers, (ii) this toxicity targets prolif-
erating cells and to a lesser extent confluent cells, but not 
quiescent or differentiated cells, (iii) the Gl/S transition is 
probably an important event, (iv), cationic voltage gated cur-
rents are observed in presence of the peptide. 
It is noteworthy that a relationship exists between the cell 
cycle and plasma membrane polarization. The relationship 
between K+ channels [18] and cell proliferation has been de-
scribed in several cell lines including T lymphocytes [19], sea 
urchin embryos [20], human mammary tumor cells (MCF-7) 
[21], Chinese hamster lung cell (V79) [22], human melanoma 
cells (IGR-1) [18], tumor cells from the anterior pituitary 
gland (GH3) [23] and neuroblastoma cells (Neuro-2A) [24]. 
The membrane potential strongly depends on the K+ channel 
state [21,22]. Furthermore, during the cell cycle, both K+ 
channels and membrane potential vary; a membrane hyper-
polarization occurs in proliferating cell lines, particularly at 
the Gl/S phase transition [19,21,23], due to the opening of 
type n K+ channels and their increased number [19]. The 
current opinion is that calcium ions are released (1-10 |a.M) 
[19] from internal stocks, which initiates the calcium depend-
ent cell cycle events including phosphorylation of p34cdc2 pro-
tein. [18,20]. Membrane potential rises at the Gl/S phase 
boundary and it remains high throughout the G2 and M 
phases [22,23]. 
As a relation exists between outward K+ current and inter-
nal Ca2+ release, a simple hypothesis could be that cationic 
input current due to the peptide cancels the K+ output current 
due to the Gl/S transition. Internal Ca2+ is released, possibly 
until total depletion. Concurrently, calcium dependent phos-
phorylation of cyclins may be elevated. This mechanism may 
be true if the membrane potential rises to more negative val-
ues, i.e. when the cells synthesize DNA. The membrane po-
tential is not always negative enough to reach the gating po-
tential; the phosphate ions change this gating potential 
toward less negative values (by 30 mV in Xenopus laevis oo-
cytes), so that most proliferating cells fall into this category 
and die. On the other hand, the observation on contiguous 
mitotic and non-mitotic cells shows that their membrane po-
tentials are coupled; the membrane potentials of mitotic con-
tiguous cells have less negative values than those of isolated 
mitotic cells [22]. A similar observation has been made with 
respect to the maturation of macrophages between blood and 
body tissue [19]. The preceding argument explains the de-
crease in toxicity (30%) observed in confluent cells, with re-
spect to proliferating non-confluent cells. 
The resulting peptide toxicity was also observed in 
synchronized cells (REF 52) in the course of vectorization 
experiments. No cell death was observed when contact oc-
curred in the G0/G1 and S phases, while an almost complete 
destruction of the cell cultures occurred when the peptide was 
applied in the late S, G2 or mitotic phases (results not shown). 
This result reinforces the relation between toxicity, prolifera-
tion and cell cycle in another cell line. 
5. Conclusion 
The toxicity of the synthetic peptide studied seems strongly 
related to the cell cycle, more precisely to the hyperpolariza-
tion occurring at the Gl/S transition. The explanation given 
as a first hypothesis concerns the inward cationic current in-
duced by the peptide which counterbalances K+ efflux current 
and the subsequent internal calcium mobilization. This hy-
pothesis has to be strengthened in future studies and extended 
to more cell lines. Nevertheless, it is clear that the toxicity 
targets proliferating cells. 
One might hope that this kind of toxicity could be used in 
vivo to kill certain cancerous cells, particularly metastatic 
cells. We propose to analyze this possibility in future work 
by studying the same cancerous cell line in vitro and in vivo. 
The fine understanding of the mechanism by which the tox-
icity acts may guide us toward a design of a molecule mim-
icking the peptide used in this work. 
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